PRESS RELEASE published on 06/21/2024 at 09:30, 2 years 3 months ago Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corporate Groupe, membre du Comité exécutif de Sanofi Audrey Duval Derveloy devient Vice-Présidente Exécutive, Directrice Affaires Corporate Groupe de Sanofi. Membre du Comité exécutif, elle supervisera l'engagement des parties prenantes à l'échelle mondiale Comité Exécutif Nomination Sanofi Audrey Duval Derveloy Directrice Affaires
PRESS RELEASE published on 06/21/2024 at 09:30, 2 years 3 months ago Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
BRIEF published on 06/21/2024 at 07:05, 2 years 3 months ago Sanofi renforce son leadership dans le traitement de l’hémophilie Sanofi Hémophilie ALTUVIIIO Fitusiran ISTH
BRIEF published on 06/21/2024 at 07:05, 2 years 3 months ago Sanofi strengthens its leadership in the treatment of hemophilia Sanofi Fitusiran ISTH Haemophilia ALTUVIIO
PRESS RELEASE published on 06/21/2024 at 07:00, 2 years 3 months ago Communiqué de presse : ISTH : De nouvelles données sur ALTUVIIIO et le fitusiran confortent le leadership de Sanofi dans le traitement de l’hémophilie De nouvelles données sur ALTUVIIIO et le fitusiran confortent le leadership de Sanofi dans le traitement de l’hémophilie. Sanofi présente ces avancées lors du 32ème Congrès de l'ISTH à Bangkok Sanofi Hémophilie ALTUVIIIO Fitusiran ISTH
PRESS RELEASE published on 06/21/2024 at 07:00, 2 years 3 months ago Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025 Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF published on 06/12/2024 at 20:24, 2 years 3 months ago Sanofi : Informations sur les droits de vote et actions - Mai 2024 Droits De Vote Actions Investisseurs Sanofi Mai 2024
BRIEF published on 06/12/2024 at 20:24, 2 years 3 months ago Sanofi: Information on voting rights and shares - May 2024 Voting Rights Investors Actions Sanofi May 2024
PRESS RELEASE published on 06/12/2024 at 20:19, 2 years 3 months ago Sanofi: Informations relatives au nombre de droits de vote et d'actions - Mai 2024 Analyse des droits de vote et d'actions de Sanofi selon les réglementations en vigueur Autorité Des Marchés Financiers Droits De Vote Actions Règlement Général Sanofi
PRESS RELEASE published on 06/12/2024 at 20:19, 2 years 3 months ago Sanofi: Information concerning the total number of voting rights and shares – May 2024 Sanofi discloses total number of voting rights and shares as per French commercial code and stock market authority regulations. Details available on Sanofi's website Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
Published on 09/26/2026 at 01:00, 14 hours 13 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 14 hours 13 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 16 hours 58 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 21 hours 43 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 07:45, 7 hours 28 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 15 hours 12 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 20 hours 43 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 21 hours 13 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:45, 21 hours 28 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 21 hours 33 minutes ago Availability of the 2026 half-year financial report